PMV Pharmaceuticals, Inc.

Historical 13F Holders

Symbol
PMVP
CUSIP
69353Y103
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 64 37.5 M $52.5 M
2025 Q2 56 35.3 M $37.4 M
2025 Q1 58 37.3 M $40.7 M
2024 Q4 73 39.0 M $58.8 M
2024 Q3 78 39.0 M $58.2 M
2024 Q2 98 40.8 M $66.1 M
2024 Q1 106 43.7 M $74.3 M
2023 Q4 108 51.6 M $160 M
2023 Q3 115 56.9 M $349 M
2023 Q2 110 51.8 M $324 M
2023 Q1 117 51.5 M $246 M
2022 Q4 124 57.9 M $503 M
2022 Q3 128 58.3 M $694 M
2022 Q2 117 61.1 M $871 M
2022 Q1 118 55.3 M $1.15 B
2021 Q4 109 47.6 M $1.10 B
2021 Q3 93 44.0 M $1.31 B
2021 Q2 89 43.0 M $1.47 B
2021 Q1 83 40.7 M $1.34 B
2020 Q4 74 38.2 M $2.34 B
2020 Q3 54 31.2 M $1.10 B